京颗粒通过调节粘脂蛋白1的表达减轻了Coxsackievirus B3引起的心肌损伤
Bowen Sun1, Lin Lin1, Tian Yao1
1Innovation Research Institute of traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China.
Journal of ethnopharmacology
|November 11, 2023
概括
京颗粒 (JFG) 通过增强自和线粒体功能的作用,可以预防Coxsackievirus B3诱导的病毒性心肌炎 (VMC). 这种传统草药可减少心脏损伤并抑制细胞亡,为VMC提供潜在的治疗策略.
科学领域:
- 心血管研究研究心血管研究
- 免疫学 免疫学 免疫学
- 传统中国医药 传统中国医药
背景情况:
- 京方颗粒 (JFG) 是源自用于病毒性疾病的传统草药配方.
- 治疗病毒性心肌炎 (VMC) 的JFG机制需要进一步调查.
- 考克萨基病毒B3 (CVB3) 是病毒性心肌炎的常见原因.
研究的目的:
- 评估JFG对CVB3诱导的VMC的治疗疗效.
- 阐明JFG在VMC治疗中的潜在分子机制.
主要方法:
- 建立了CVB3诱导的VMC的小鼠模型,并用JFG或oseltamivir进行治疗.
- 分析了心脏病理,炎症标志物和基因表达.
- 转录组分析确定了Mcoln1作为一个关键基因;其作用在H9C2细胞中使用siRNA敲除和各种细胞测试 (qRT-PCR,JC-1染色,ROS检测) 进行了研究.
主要成果:
- 在VMC小鼠中,JFG治疗显著降低了心脏病理损伤和炎症基因表达.
- 转录组分析揭示了Mcoln1上调,这促进了自和清除受损的线粒体和活性氧物种 (ROS).
- 实验室研究证实,Mcoln1在H9C2细胞中的敲除损害了JFG增强自,改善线粒体功能,清除ROS和抑制亡的能力.
结论:
- JFG证明了对CVB3诱导的H9C2细胞损伤的保护作用.
- JFG很可能通过增强通过线粒体通路的自,抑制细胞亡和减轻细胞损伤来对VMC产生治疗作用.
相关概念视频
Myocarditis III: Medical Management
7
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
7
Heart Failure Drugs: Inotropic Agents
598
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
598


